These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 26739101)

  • 1. Whole Exome Sequencing and Heterologous Cellular Electrophysiology Studies Elucidate a Novel Loss-of-Function Mutation in the CACNA1A-Encoded Neuronal P/Q-Type Calcium Channel in a Child With Congenital Hypotonia and Developmental Delay.
    Weyhrauch DL; Ye D; Boczek NJ; Tester DJ; Gavrilova RH; Patterson MC; Wieben ED; Ackerman MJ
    Pediatr Neurol; 2016 Feb; 55():46-51. PubMed ID: 26739101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel CACNA1A variant in a child with early stroke and intractable epilepsy.
    Gudenkauf FJ; Azamian MS; Hunter JV; Nayak A; Lalani SR
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1383. PubMed ID: 32692472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early onset, non fluctuating spinocerebellar ataxia and a novel missense mutation in CACNA1A gene.
    Tonelli A; D'Angelo MG; Salati R; Villa L; Germinasi C; Frattini T; Meola G; Turconi AC; Bresolin N; Bassi MT
    J Neurol Sci; 2006 Feb; 241(1-2):13-7. PubMed ID: 16325861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo KCNH1 mutations in four patients with syndromic developmental delay, hypotonia and seizures.
    Fukai R; Saitsu H; Tsurusaki Y; Sakai Y; Haginoya K; Takahashi K; Hubshman MW; Okamoto N; Nakashima M; Tanaka F; Miyake N; Matsumoto N
    J Hum Genet; 2016 May; 61(5):381-7. PubMed ID: 26818738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing study of partial agenesis of the corpus callosum in men with developmental delay, epilepsy, and microcephaly.
    Meloche J; Brunet V; Gagnon PA; Lavoie MÈ; Bouchard JB; Nadaf J; Majewski J; Morin C; Laprise C
    Mol Genet Genomic Med; 2020 Jan; 8(1):e992. PubMed ID: 31578829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
    DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
    J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A.
    García Segarra N; Gautschi I; Mittaz-Crettol L; Kallay Zetchi C; Al-Qusairi L; Van Bemmelen MX; Maeder P; Bonafé L; Schild L; Roulet-Perez E
    J Neurol Sci; 2014 Jul; 342(1-2):69-78. PubMed ID: 24836863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of whole exome sequencing for syndromic retinal dystrophy diagnosis in young patients.
    Prokudin I; Li D; He S; Guo Y; Goodwin L; Wilson M; Rose L; Tian L; Chen Y; Liang J; Keating B; Xu X; Jamieson RV; Hakonarson H
    Clin Exp Ophthalmol; 2015 Mar; 43(2):132-8. PubMed ID: 25060287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation.
    Venkateswaran S; Myers KA; Smith AC; Beaulieu CL; Schwartzentruber JA; ; Majewski J; Bulman D; Boycott KM; Dyment DA
    Epilepsia; 2014 Jul; 55(7):e75-9. PubMed ID: 24903190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy.
    Reinson K; Õiglane-Shlik E; Talvik I; Vaher U; Õunapuu A; Ennok M; Teek R; Pajusalu S; Murumets Ü; Tomberg T; Puusepp S; Piirsoo A; Reimand T; Õunap K
    Am J Med Genet A; 2016 Aug; 170(8):2173-6. PubMed ID: 27250579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The de novo CACNA1A pathogenic variant Y1384C associated with hemiplegic migraine, early onset cerebellar atrophy and developmental delay leads to a loss of Cav2.1 channel function.
    Gandini MA; Souza IA; Ferron L; Innes AM; Zamponi GW
    Mol Brain; 2021 Feb; 14(1):27. PubMed ID: 33557884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically severe CACNA1A alleles affect synaptic function and neurodegeneration differentially.
    Luo X; Rosenfeld JA; Yamamoto S; Harel T; Zuo Z; Hall M; Wierenga KJ; Pastore MT; Bartholomew D; Delgado MR; Rotenberg J; Lewis RA; Emrick L; Bacino CA; Eldomery MK; Coban Akdemir Z; Xia F; Yang Y; Lalani SR; Lotze T; Lupski JR; Lee B; Bellen HJ; Wangler MF;
    PLoS Genet; 2017 Jul; 13(7):e1006905. PubMed ID: 28742085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?
    Horvath GA; Demos M; Shyr C; Matthews A; Zhang L; Race S; Stockler-Ipsiroglu S; Van Allen MI; Mancarci O; Toker L; Pavlidis P; Ross CJ; Wasserman WW; Trump N; Heales S; Pope S; Cross JH; van Karnebeek CD
    Mol Genet Metab; 2016 Jan; 117(1):42-8. PubMed ID: 26647175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel de novo SPOCK1 mutation in a proband with developmental delay, microcephaly and agenesis of corpus callosum.
    Dhamija R; Graham JM; Smaoui N; Thorland E; Kirmani S
    Eur J Med Genet; 2014 Mar; 57(4):181-4. PubMed ID: 24583203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hypotonia and postnatal growth impairment in a girl with a missense mutation in COL1A1: Implication of expanded phenotypic spectrum of type I collagenopathy.
    Lee JS; Seo J; Cho A; Lim BC; Choi M; Kim JW; Kim OH; Cho TJ; Chae JH
    Brain Dev; 2017 Oct; 39(9):799-803. PubMed ID: 28668235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome.
    Jiang X; Raju PK; D'Avanzo N; Lachance M; Pepin J; Dubeau F; Mitchell WG; Bello-Espinosa LE; Pierson TM; Minassian BA; Lacaille JC; Rossignol E
    Epilepsia; 2019 Sep; 60(9):1881-1894. PubMed ID: 31468518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo GRIN1 mutations: An emerging cause of severe early infantile encephalopathy.
    Zehavi Y; Mandel H; Zehavi A; Rashid MA; Straussberg R; Jabur B; Shaag A; Elpeleg O; Spiegel R
    Eur J Med Genet; 2017 Jun; 60(6):317-320. PubMed ID: 28389307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome reports A de novo GNB2 variant associated with global developmental delay, intellectual disability, and dysmorphic features.
    Fukuda T; Hiraide T; Yamoto K; Nakashima M; Kawai T; Yanagi K; Ogata T; Saitsu H
    Eur J Med Genet; 2020 Apr; 63(4):103804. PubMed ID: 31698099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ataxic groggy rat has a missense mutation in the P/Q-type voltage-gated Ca2+ channel alpha1A subunit gene and exhibits absence seizures.
    Tokuda S; Kuramoto T; Tanaka K; Kaneko S; Takeuchi IK; Sasa M; Serikawa T
    Brain Res; 2007 Feb; 1133(1):168-77. PubMed ID: 17196942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.